Article info
Editorial commentary
First approved treatment in children with multiple sclerosis slows brain atrophy
- Correspondence to Dr Arman Eshaghi, Queen Square Multiple Sclerosis Centre, Department of Neuroinflammation, UCL Queen Square Institute of Neurology, Faculty of Brain Sciences, University College London, London WC1B 5EH, UK; a.eshaghi{at}ucl.ac.uk
Citation
First approved treatment in children with multiple sclerosis slows brain atrophy
Publication history
- Received November 27, 2019
- Accepted December 2, 2019
- First published March 4, 2020.
Online issue publication
April 15, 2020
Article Versions
- Previous version (4 March 2020).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.